Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.05.19.654678

Within-host viral evolution varies with T cell receptor repertoire diversity independently of viral mutation rates

Abstract

The specific T cell receptors (TCRs) present in an individual determine which antigens can be recognized, and hence a repertoire comprised of a vast number of unique TCRs ensures an effective T cell response can be mounted against a broad range of potential pathogens encountered. To evade the T cell response, pathogens, and viruses in particular, can accrue epitope escape mutations, establishing a host-pathogen tug-of-war between T cell-mediated control and viral evolution. Indeed, the evolutionary significance of TCR diversification in mammals is underscored by the sophisticated molecular machinery - spanning from somatic V(D)J recombination through non-templated nucleotide additions - that establish the TCR repertoire. Yet, whether greater oligoclonality among responding T cells, as is the case for elderly or immunocompromised individuals, might therefore accelerate pathogen immune escape remains unclear. Here, we constructed a computational model of T cell-mediated viral evolution to investigate how the number of unique virus-specific T cells clones impacts the balance between curtailing viral load through cross-reactivity to mutant strains on the one hand, versus promoting the generation of escape variants on the other. The model recapitulated prior experimental findings, such as T cell-dependent emergence of new viral mutants and the progressive decrease in the number of T cell clones present in the response over time. Our model simulations suggested that oligoclonality in the virus-specific T cell response can, if coupled with a resulting increase in viral replication, maximize viral immune escape despite constant mutation rates revealing a mechanism for how viruses with comparable mutation rates can nonetheless exhibit dramatically different adaption rates within hosts. Taken together, the model results suggest that variations in TCR repertoire diversity, and consequently in the number of pathogen-specific T cell clones within an individual, can have direct, non-linear impacts on viral immune escape.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jamaleddine, H., Khadra, A., Mandl, J. N.. 2025-05-24. Within-host viral evolution varies with T cell receptor repertoire diversity independently of viral mutation rates. https://doi.org/10.1101/2025.05.19.654678

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Common viral infections seed regionally distinct resident memory T cells in the human CNS

T cells persist in the central nervous system (CNS) and can drive both protection and neurological disease. How these cells are organized in humans and what they recognize is largely unknown. Here, we profiled CD8 T cells across anatomically distinct CNS regions, obtained through on-site autopsies and temporal lobe resection surgeries, using single-cell RNA sequencing, paired T cell receptor sequencing, and DNA-barcoded tetramers. Resident memory T cells (TRM) specific for Epstein-Barr virus, cytomegalovirus, influenza A, and SARS-CoV-2 were identified across CNS compartments. Anatomical location was the strongest correlate of TRM cell state, with leptomeningeal cells adopting a cytokine-poised TRM program, whereas brain TRM cells were transcriptionally restrained. Cells of the same clonotype spanned tissues yet adopted local transcriptional states. Viral specificity added another layer of TRM heterogeneity with GZMK/GZMA-expressing EBV-specific populations and interferon-stimulated gene signatures in SARS-CoV-2 and Influenza A-specific cells. The human CNS thus harbors regionally distinct CD8+ TRM shaped by common viral exposures.

immunology↗

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

Rheumatic diseases, including rheumatoid arthritis (RA), spondyloarthritis (SpA) and osteoarthritis (OA), show distinct phenotypes yet respond to overlapping therapies, implicating shared immune mechanisms. In the Transimmunom cohort, we profiled peripheral blood from 240 individuals (47 healthy, 44 OA, 91 RA, 58 SpA) across deep immunophenotyping, immunoproteomics and Treg-Teff transcriptomics. Single-layer analyses revealed broader Treg than Teff remodeling, along with a shared pattern of reduced activated Tregs and expanded Helios+ Tregs across all diseases, alongside a decrease in functional Treg subpopulations, including CTLA4+ and CD45RA- Tregs. In RA specifically, LAG3+ Tregs were also expanded. Combining omics layers outperformed single-layer approaches for disease classification. Among individual layers, Treg transcriptomes were most discriminative, and integration uncovered disease-specific programs. Unsupervised clustering identified a cross-disease cluster independent of activity, treatment and age, mapping to early disease (<= years) and dominated by a Treg dysfunction-associated program. These results provide a biological rationale for the therapeutic "window of opportunity" concept and duration-stratified Treg-directed trials.

immunology↗

Inhibitory Fc Receptor sets a time limit on macrophage response to IgG

Antibodies engage both activating Fc Receptors and the inhibitory receptor Fc{gamma}RIIB. Why macrophages need a dedicated inhibitory receptor rather than simply tuning activating receptor signaling is unclear. Using DNA-based chimeric receptors and in silico modeling, we independently controlled activating and inhibitory Fc Receptors. We found that Fc{gamma}RIIB imposed a time limit on macrophage phagocytosis and ERK signaling. The time limit is due to activating Fc Receptors converting PI(4,5)P2 to PI(3,4,5)P3, which is subsequently converted to PI(3,4)P2 by Fc{gamma}RIIB. This leads to a pulse of active signaling, which is sufficient for phagocytosis of small bacteria-sized targets but not phagocytosis of large targets and TNF secretion. Unlike engaging Fc{gamma}RIIB, reducing activating Fc Receptor signaling decreased initiation of phagocytosis, the speed of PI(3,4,5)P3 generation, and the amplitude of ERK signaling. Our results demonstrate that Fc{gamma}RIIB controls the duration of IgG signaling, while the activating Fc Receptors control sensitivity.

immunology↗